Search Results

Transdermal Delivery of Treatment for Alzheimer's Disease: Development, Clinical Performance and Future Prospects

Authors: Chan, Agnes L.F.; Chien, Yie W.; Shun Jin Lin,

Source: Drugs & Aging, Volume 25, Number 9, 2008 , pp. 761-775(15)

Publisher: Adis International

The oxidation products of melatonin derivatives exhibit acetylcholinesterase and butyrylcholinesterase inhibitory activity

Authors: Siwicka, Aleksandra; Molęda, Zuzanna; Wojtasiewicz, Krystyna; Zawadzka, Anna; Maurin, Jan K.; Panasiewicz, Mirosława; Pacuszka, Tadeusz; Czarnocki, Zbigniew

Source: Journal of Pineal Research, Volume 45, Number 1, August 2008 , pp. 40-49(10)

Publisher: Blackwell Publishing

Practical Issues in Stem Cell Therapy for Alzheimer's Disease

Authors: Sugaya, K.; Kwak, Y. D.; Ohmitsu, O.; Marutle, A.; Greig, N. H.; Choumrina, E.

Source: Current Alzheimer Research, Volume 4, Number 4, September 2007 , pp. 370-377(8)

Publisher: Bentham Science Publishers

Phenserine

Author: Klein, Jochen

Source: Expert Opinion on Investigational Drugs, Volume 16, Number 7, July 2007 , pp. 1087-1097(11)

Publisher: Informa Healthcare

Imaging of Muscarinic Receptors in the Central Nervous System

Author: Eckelman, W. C.

Source: Current Pharmaceutical Design, Volume 12, Number 30, October 2006 , pp. 3901-3913(13)

Publisher: Bentham Science Publishers

Phenserine may be effective in patients with mild-to-moderate Alzheimer's disease

Source: Inpharma, Volume 1, Number 1517, 2005-12-10 , pp. 8-8(1)

Publisher: Adis International

Anticholinesterase and Pharmacokinetic Profile of Phenserine in Healthy Elderly Human Subjects

Authors: Greig, Nigel H.; Ruckle, Jon; Comer, Patrick; Brownell, Lidia; Holloway, Harold W.; Flanagan Jr., Douglas R.; Canfield, Craig J.; Burford, Robert G.

Source: Current Alzheimer Research, Volume 2, Number 4, October 2005 , pp. 483-492(10)

Publisher: Bentham Science Publishers

An Overview of Phenserine Tartrate, A Novel Acetylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease

Authors: Greig, Nigel H.; Sambamurti, Kumar; Yu, Qian-sheng; Brossi, Arnold; Bruinsma, Gosse B.; Lahiri, Debomoy K.

Source: Current Alzheimer Research, Volume 2, Number 3, July 2005 , pp. 281-290(10)

Publisher: Bentham Science Publishers

Pilot Study of the Reducing Effect on Amyloidosis In Vivo by Three FDA Pre-Approved Drugs Via the Alzheimer's APP 5'Untranslated Region

Authors: Tucker, Stephanie; Ahl, Michelle; Bush, Ashley; Westaway, David; Huang, Xudong; Rogers, Jack T.

Source: Current Alzheimer Research, Volume 2, Number 2, April 2005 , pp. 249-254(6)

Publisher: Bentham Science Publishers

FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein

Authors: Morse, Lee; Payton, Sandra; Cuny, Gregory; Rogers, Jack

Source: Journal of Molecular Neuroscience, Volume 24, Number 1, February 2004 , pp. 129-136(8)

Publisher: Humana Press

Tianeptine: 5-HT uptake sites and 5-HT_1-7 receptors modulate memory formation in an autoshaping Pavlovian/instrumental task

Author: Meneses A.

Source: Neuroscience and Biobehavioral Reviews, Volume 26, Number 3, May 2002 , pp. 309-319(11)

Publisher: Elsevier

Alzheimer's Disease: An Overview of Current and Emerging Therapeutic Strategies

Author: Jacobsen, J.

Source: Current Topics in Medicinal Chemistry, Volume 2, Number 4, 1 April 2002 , pp. 343-352(10)

Publisher: Bentham Science Publishers

Phenserine is well tolerated in patients with mild-to-moderate Alzheimer's disease

Source: Inpharma, Volume 1, Number 1312, 2001 , pp. 13-13(1)

Publisher: Adis International

Cholinesterase inhibitors, β-amyloid precursor protein and amyloid β-peptides in Alzheimer's disease

Authors: Lahiri, D. K.; Farlow, M. R.; Hintz, N.; Utsuki, T.; Greig, N. H.

Source: Acta Neurologica Scandinavica, Volume 102, Supplement 176, December 2000 , pp. 60-67(8)

Publisher: Blackwell Publishing

The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics

Authors: Greig, N. H.; De Micheli, E.; Holloway, H. W.; Yu, Q.-S.; Utsuki, T.; Perry, T. A.; Ingram, D. K.; Deutsch, J.; Lahiri, D.; Soncrant, T. T.

Source: Acta Neurologica Scandinavica, Volume 102, Supplement 176, December 2000 , pp. 74-84(11)

Publisher: Blackwell Publishing

Kinetics of human acetylcholinesterase inhibition by the novel experimental alzheimer therapeutic agent, tolserine

Authors: Kamal M.A.; Greig N.H.; Alhomida A.S.; Al-Jafari A.A.

Source: Biochemical Pharmacology, Volume 60, Number 4, 15 August 2000 , pp. 561-570(10)

Publisher: Elsevier

Simplified methods for in vivo measurement of acetylcholinesterase activity in rodent brain - An irreversible tracer for mapping AChE activity

Authors: Kilbourn M.R.; Sherman P.S.; Snyder S.E.

Source: Nuclear Medicine and Biology, Volume 26, Number 5, July 1999 , pp. 543-550(8)

Publisher: Elsevier

Kinetics of Human Erythrocyte Acetylcholinesterase Inhibition by a Novel Derivative of Physostigmine: Phenserine

Authors: Al-Jafari A.A.; Kamal M.A.; Greig N.H.; Alhomida A.S.; Perry E.R.

Source: Biochemical and Biophysical Research Communications, Volume 248, Number 1, 9 July 1998 , pp. 180-185(6)

Publisher: Elsevier

Sensitivity of bovine retinal acetylcholinesterase to phenserine: A derivative of physostigmine

Authors: Al-Jafari A.A.; Kamal M.A.; Greig N.H.

Source: Journal of Physiology-Paris, Volume 92, Number 5, October 1998 , pp. 402-402(1)

Publisher: Elsevier

Kinetics of Human Erythrocyte Acetylcholinesterase Inhibition by a Novel Derivative of Physostigmine: Phenserine

Authors: Al-Jafari A.A.; Kamal M.A.; Greig N.H.; Alhomida A.S.; Perry E.R.

Source: Biochemical and Biophysical Research Communications, Volume 248, Number 1, July 1998 , pp. 180-185(6)

Publisher: Academic Press